We report a case of mpox in a patient with a signal transducer and activator of transcription 1 gain-of-function mutation. Despite initial improvement with intravenous immune globulin and tecovirimat, severe symptoms developed and the patient died. This underscores the need for immune system optimization and effective virucidal treatments for mpox.
View Full-Length Video at: https://youtu.be/UHajiOZrY1gRelated Article Available at: https://mayocl.in/4kgh9Tq
Guides: W. Bruce Fye Center For the History of Medicine: A Century of Mayo Clinic Proceedings
A local male in his mid-40s had a 10-year history of pain over both clavicles and sternoclavicular joints. In May 2023, he visited the outpatient…
To examine the association of “weekend warrior” (WW) pattern and physical activity distributed throughout the week with mortality risk.
Hepatocellular carcinoma (HCC) is the second leading cause of global cancer-related death, and more than 80% of the global burden is borne by lower income…
This 2-cm mass was identified in the second portion of the duodenum in an adult. Pathologic examination diagnosed the tumor as a composite gangliocytoma/neuroma and…
Risk stratification for transcatheter aortic valve replacement (TAVR) uses risk scores derived solely from clinical variables. However, there is growing recognition of the potential role…
A 28-year-old woman presented to the neurology outpatient clinic reporting a 2-year history of spells that were initially occurring once weekly and lasting 15 to…
An adult male who had chronic myelomonocytic leukemia was evaluated for 3 months of hemorrhagic bullae on the hands. Empiric antimicrobial therapy with linezolid, Bactrim,…
The number of highly sensitized patients in need of a multiorgan transplant is increasing. Criteria informing their transplant candidacy, approaches to management on the waitlist,…
